Pediatric Asthma Treatment Market 2027 By Product type, Drug class, Route of administration and Geography | The Insight Partners

Pediatric Asthma Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product type (Dry powder inhalers, Metered dose inhalers, Mist inhalers, Nebulizer); Drug class (Anti-inflammatory drugs, Bronchodilators, Combination therapy); Route of administration (Oral, Inhaled, Intravenous, Subcutaneous) and Geography

Report Code: TIPRE00015283 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Asthma is a chronic disease which shows various symptoms such as coughing, wheezing, chest tightness and breath shortness. Environmental and genetic factors are major cause of the asthma. The environmental factors include exposure to air pollution, pollen grains and allergens. The pulmonary airway muscles get swollen due to allergens, which cause bronchospasm and airway obstruction. Patients with genetic history of asthma are more prone to developing asthma. Asthma can be controlled by early asthma treatment. The medications include long acting beta-agonists (LABA), corticosteroids, anti-inflammatory agents and leukotriene modifiers. Asthma patients are always at risk of developing with pneumonia and influenza. Diagnosis and treatment of asthma in pediatric has remained a challenge.

MARKET DYNAMICS

The pediatric asthma treatment market is growing due to the rise in asthma incidences and growing allergy cases. However, the high cost of pediatric asthma treatment is expected to hamper the growth of the global pediatric asthma treatment market.

MARKET SCOPE

The "Pediatric Asthma Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Pediatric Asthma Treatment market with detailed market segmentation product type, drug class, route of administration and geography. The Pediatric Asthma Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Pediatric Asthma Treatment market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Pediatric Asthma Treatment market is segmented on the basis of product type, drug class and route of administration. Based on products type, the market is segmented as dry powder inhalers, metered dose inhalers, mist inhalers and nebulizer. On the basis of drug class, the global asthma therapeutics market is segmented into anti-inflammatory drugs, bronchodilators and combination therapy. Based on route of administration, the market segmented into oral, inhaled, intravenous and subcutaneous.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Pediatric Asthma Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Pediatric Asthma Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Pediatric Asthma Treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Pediatric Asthma Treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Pediatric Asthma Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Pediatric Asthma Treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for Pediatric Asthma Treatment in the global market. Below mentioned is the list of few companies engaged in the Pediatric Asthma Treatment market.

The report also includes the profiles of key players in Pediatric Asthma Treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Teva Pharmaceutical Industries Ltd.
  •  Merck KGaA
  •  GlaxoSmithKline Plc
  •  F. Hoffmann La-Roche Ltd.
  •  AstraZeneca Plc
  •  Boehringer Ingelheim GmbH
  •  Sanofi SA
  •  Sunovion Pharmaceuticals, Inc.
  •  CareFusion Corporation
  •  Philips Healthcare

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pediatric Asthma Treatment Market - By Product type
1.3.2 Pediatric Asthma Treatment Market - By Drug class
1.3.3 Pediatric Asthma Treatment Market - By Route of administration
1.3.4 Pediatric Asthma Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PEDIATRIC ASTHMA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. PEDIATRIC ASTHMA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PEDIATRIC ASTHMA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. PEDIATRIC ASTHMA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. PEDIATRIC ASTHMA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PEDIATRIC ASTHMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. DRY POWDER INHALERS
7.3.1. Overview
7.3.2. Dry powder inhalers Market Forecast and Analysis
7.4. METERED DOSE INHALERS
7.4.1. Overview
7.4.2. Metered dose inhalers Market Forecast and Analysis
7.5. MIST INHALERS
7.5.1. Overview
7.5.2. Mist inhalers Market Forecast and Analysis
7.6. NEBULIZER
7.6.1. Overview
7.6.2. Nebulizer Market Forecast and Analysis
8. PEDIATRIC ASTHMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
8.1. OVERVIEW
8.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
8.3. ANTI-INFLAMMATORY DRUGS
8.3.1. Overview
8.3.2. Anti-inflammatory drugs Market Forecast and Analysis
8.4. BRONCHODILATORS
8.4.1. Overview
8.4.2. Bronchodilators Market Forecast and Analysis
8.5. COMBINATION THERAPY
8.5.1. Overview
8.5.2. Combination therapy Market Forecast and Analysis
9. PEDIATRIC ASTHMA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
9.1. OVERVIEW
9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
9.3. ORAL
9.3.1. Overview
9.3.2. Oral Market Forecast and Analysis
9.4. INHALED
9.4.1. Overview
9.4.2. Inhaled Market Forecast and Analysis
9.5. INTRAVENOUS
9.5.1. Overview
9.5.2. Intravenous Market Forecast and Analysis
9.6. SUBCUTANEOUS
9.6.1. Overview
9.6.2. Subcutaneous Market Forecast and Analysis
10. PEDIATRIC ASTHMA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pediatric Asthma Treatment Market Overview
10.1.2 North America Pediatric Asthma Treatment Market Forecasts and Analysis
10.1.3 North America Pediatric Asthma Treatment Market Forecasts and Analysis - By Product type
10.1.4 North America Pediatric Asthma Treatment Market Forecasts and Analysis - By Drug class
10.1.5 North America Pediatric Asthma Treatment Market Forecasts and Analysis - By Route of administration
10.1.6 North America Pediatric Asthma Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pediatric Asthma Treatment Market
10.1.6.1.1 United States Pediatric Asthma Treatment Market by Product type
10.1.6.1.2 United States Pediatric Asthma Treatment Market by Drug class
10.1.6.1.3 United States Pediatric Asthma Treatment Market by Route of administration
10.1.6.2 Canada Pediatric Asthma Treatment Market
10.1.6.2.1 Canada Pediatric Asthma Treatment Market by Product type
10.1.6.2.2 Canada Pediatric Asthma Treatment Market by Drug class
10.1.6.2.3 Canada Pediatric Asthma Treatment Market by Route of administration
10.1.6.3 Mexico Pediatric Asthma Treatment Market
10.1.6.3.1 Mexico Pediatric Asthma Treatment Market by Product type
10.1.6.3.2 Mexico Pediatric Asthma Treatment Market by Drug class
10.1.6.3.3 Mexico Pediatric Asthma Treatment Market by Route of administration
10.2. EUROPE
10.2.1 Europe Pediatric Asthma Treatment Market Overview
10.2.2 Europe Pediatric Asthma Treatment Market Forecasts and Analysis
10.2.3 Europe Pediatric Asthma Treatment Market Forecasts and Analysis - By Product type
10.2.4 Europe Pediatric Asthma Treatment Market Forecasts and Analysis - By Drug class
10.2.5 Europe Pediatric Asthma Treatment Market Forecasts and Analysis - By Route of administration
10.2.6 Europe Pediatric Asthma Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pediatric Asthma Treatment Market
10.2.6.1.1 Germany Pediatric Asthma Treatment Market by Product type
10.2.6.1.2 Germany Pediatric Asthma Treatment Market by Drug class
10.2.6.1.3 Germany Pediatric Asthma Treatment Market by Route of administration
10.2.6.2 France Pediatric Asthma Treatment Market
10.2.6.2.1 France Pediatric Asthma Treatment Market by Product type
10.2.6.2.2 France Pediatric Asthma Treatment Market by Drug class
10.2.6.2.3 France Pediatric Asthma Treatment Market by Route of administration
10.2.6.3 Italy Pediatric Asthma Treatment Market
10.2.6.3.1 Italy Pediatric Asthma Treatment Market by Product type
10.2.6.3.2 Italy Pediatric Asthma Treatment Market by Drug class
10.2.6.3.3 Italy Pediatric Asthma Treatment Market by Route of administration
10.2.6.4 Spain Pediatric Asthma Treatment Market
10.2.6.4.1 Spain Pediatric Asthma Treatment Market by Product type
10.2.6.4.2 Spain Pediatric Asthma Treatment Market by Drug class
10.2.6.4.3 Spain Pediatric Asthma Treatment Market by Route of administration
10.2.6.5 United Kingdom Pediatric Asthma Treatment Market
10.2.6.5.1 United Kingdom Pediatric Asthma Treatment Market by Product type
10.2.6.5.2 United Kingdom Pediatric Asthma Treatment Market by Drug class
10.2.6.5.3 United Kingdom Pediatric Asthma Treatment Market by Route of administration
10.2.6.6 Rest of Europe Pediatric Asthma Treatment Market
10.2.6.6.1 Rest of Europe Pediatric Asthma Treatment Market by Product type
10.2.6.6.2 Rest of Europe Pediatric Asthma Treatment Market by Drug class
10.2.6.6.3 Rest of Europe Pediatric Asthma Treatment Market by Route of administration
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pediatric Asthma Treatment Market Overview
10.3.2 Asia-Pacific Pediatric Asthma Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Pediatric Asthma Treatment Market Forecasts and Analysis - By Product type
10.3.4 Asia-Pacific Pediatric Asthma Treatment Market Forecasts and Analysis - By Drug class
10.3.5 Asia-Pacific Pediatric Asthma Treatment Market Forecasts and Analysis - By Route of administration
10.3.6 Asia-Pacific Pediatric Asthma Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pediatric Asthma Treatment Market
10.3.6.1.1 Australia Pediatric Asthma Treatment Market by Product type
10.3.6.1.2 Australia Pediatric Asthma Treatment Market by Drug class
10.3.6.1.3 Australia Pediatric Asthma Treatment Market by Route of administration
10.3.6.2 China Pediatric Asthma Treatment Market
10.3.6.2.1 China Pediatric Asthma Treatment Market by Product type
10.3.6.2.2 China Pediatric Asthma Treatment Market by Drug class
10.3.6.2.3 China Pediatric Asthma Treatment Market by Route of administration
10.3.6.3 India Pediatric Asthma Treatment Market
10.3.6.3.1 India Pediatric Asthma Treatment Market by Product type
10.3.6.3.2 India Pediatric Asthma Treatment Market by Drug class
10.3.6.3.3 India Pediatric Asthma Treatment Market by Route of administration
10.3.6.4 Japan Pediatric Asthma Treatment Market
10.3.6.4.1 Japan Pediatric Asthma Treatment Market by Product type
10.3.6.4.2 Japan Pediatric Asthma Treatment Market by Drug class
10.3.6.4.3 Japan Pediatric Asthma Treatment Market by Route of administration
10.3.6.5 South Korea Pediatric Asthma Treatment Market
10.3.6.5.1 South Korea Pediatric Asthma Treatment Market by Product type
10.3.6.5.2 South Korea Pediatric Asthma Treatment Market by Drug class
10.3.6.5.3 South Korea Pediatric Asthma Treatment Market by Route of administration
10.3.6.6 Rest of Asia-Pacific Pediatric Asthma Treatment Market
10.3.6.6.1 Rest of Asia-Pacific Pediatric Asthma Treatment Market by Product type
10.3.6.6.2 Rest of Asia-Pacific Pediatric Asthma Treatment Market by Drug class
10.3.6.6.3 Rest of Asia-Pacific Pediatric Asthma Treatment Market by Route of administration
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pediatric Asthma Treatment Market Overview
10.4.2 Middle East and Africa Pediatric Asthma Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Pediatric Asthma Treatment Market Forecasts and Analysis - By Product type
10.4.4 Middle East and Africa Pediatric Asthma Treatment Market Forecasts and Analysis - By Drug class
10.4.5 Middle East and Africa Pediatric Asthma Treatment Market Forecasts and Analysis - By Route of administration
10.4.6 Middle East and Africa Pediatric Asthma Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pediatric Asthma Treatment Market
10.4.6.1.1 South Africa Pediatric Asthma Treatment Market by Product type
10.4.6.1.2 South Africa Pediatric Asthma Treatment Market by Drug class
10.4.6.1.3 South Africa Pediatric Asthma Treatment Market by Route of administration
10.4.6.2 Saudi Arabia Pediatric Asthma Treatment Market
10.4.6.2.1 Saudi Arabia Pediatric Asthma Treatment Market by Product type
10.4.6.2.2 Saudi Arabia Pediatric Asthma Treatment Market by Drug class
10.4.6.2.3 Saudi Arabia Pediatric Asthma Treatment Market by Route of administration
10.4.6.3 U.A.E Pediatric Asthma Treatment Market
10.4.6.3.1 U.A.E Pediatric Asthma Treatment Market by Product type
10.4.6.3.2 U.A.E Pediatric Asthma Treatment Market by Drug class
10.4.6.3.3 U.A.E Pediatric Asthma Treatment Market by Route of administration
10.4.6.4 Rest of Middle East and Africa Pediatric Asthma Treatment Market
10.4.6.4.1 Rest of Middle East and Africa Pediatric Asthma Treatment Market by Product type
10.4.6.4.2 Rest of Middle East and Africa Pediatric Asthma Treatment Market by Drug class
10.4.6.4.3 Rest of Middle East and Africa Pediatric Asthma Treatment Market by Route of administration
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pediatric Asthma Treatment Market Overview
10.5.2 South and Central America Pediatric Asthma Treatment Market Forecasts and Analysis
10.5.3 South and Central America Pediatric Asthma Treatment Market Forecasts and Analysis - By Product type
10.5.4 South and Central America Pediatric Asthma Treatment Market Forecasts and Analysis - By Drug class
10.5.5 South and Central America Pediatric Asthma Treatment Market Forecasts and Analysis - By Route of administration
10.5.6 South and Central America Pediatric Asthma Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pediatric Asthma Treatment Market
10.5.6.1.1 Brazil Pediatric Asthma Treatment Market by Product type
10.5.6.1.2 Brazil Pediatric Asthma Treatment Market by Drug class
10.5.6.1.3 Brazil Pediatric Asthma Treatment Market by Route of administration
10.5.6.2 Argentina Pediatric Asthma Treatment Market
10.5.6.2.1 Argentina Pediatric Asthma Treatment Market by Product type
10.5.6.2.2 Argentina Pediatric Asthma Treatment Market by Drug class
10.5.6.2.3 Argentina Pediatric Asthma Treatment Market by Route of administration
10.5.6.3 Rest of South and Central America Pediatric Asthma Treatment Market
10.5.6.3.1 Rest of South and Central America Pediatric Asthma Treatment Market by Product type
10.5.6.3.2 Rest of South and Central America Pediatric Asthma Treatment Market by Drug class
10.5.6.3.3 Rest of South and Central America Pediatric Asthma Treatment Market by Route of administration
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PEDIATRIC ASTHMA TREATMENT MARKET, KEY COMPANY PROFILES
12.1. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MERCK KGAA
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. GLAXOSMITHKLINE PLC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. F. HOFFMANN LA-ROCHE LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ASTRAZENECA PLC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BOEHRINGER INGELHEIM GMBH
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANOFI SA
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SUNOVION PHARMACEUTICALS, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CAREFUSION CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PHILIPS HEALTHCARE
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Teva Pharmaceutical Industries Ltd.
2. Merck KGaA
3. GlaxoSmithKline Plc
4. F. Hoffmann La-Roche Ltd.
5. AstraZeneca Plc
6. Boehringer Ingelheim GmbH
7. Sanofi SA
8. Sunovion Pharmaceuticals, Inc.
9. CareFusion Corporation
10. Philips Healthcare
TIPRE00015283
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking